Lilly eyes more cancer deals but wary of CART gene therapy httpsreut.rs2D5br4qÂpic.twitter.comZcyaNmoJXj
Lilly eyes more cancer deals, but wary of CAR-T, gene therapy https://reut.rs/2D5br4q pic.twitter.com/ZcyaNmoJXj
More From BioPortfolio on "Lilly eyes more cancer deals, but wary of CAR-T, gene therapy https://reut.rs/2D5br4q pic.twitter.com/ZcyaNmoJXj"